Flumazenil
Generic Details
Generic Name
Flumazenil
Other Names
- Anexate
Drug Class
- Benzodiazepine Antagonist
Chemical Formula
C15H14FN3O3
Molecular Weight
303.29 g/mol
Mechanism of Action
- Competitive antagonist at the benzodiazepine binding site on the GABA-A receptor
Indications
- Reversal of benzodiazepine-induced sedation
- Benzodiazepine overdose
- Diagnostic tool in coma of unknown etiology
Common Dosage Forms
- Injection
- Oral tablet
Typical Dosage
- 0.2 mg to 1 mg IV/IM
- 0.2 mg to 1 mg orally
Pediatric Dosage
- Safety and efficacy not established
Geriatric Dosage
- Dose reduction may be required due to potential age-related decrease in hepatic function
Side Effects
- Flushing
- Nausea
- Dizziness
- Headache
- Injection site reactions
Contraindications
- Hypersensitivity to flumazenil or benzodiazepines
- Patients with a history of seizures
Pregnancy Category
- C - Use with caution if benefits outweigh risks
Lactation Safety
- Limited data available, use with caution
Drug Interactions
- May decrease the efficacy of long-acting benzodiazepines if given for dependence
Overdose Symptoms
- Seizures
- Hypotension
- Cardiorespiratory depression
Antidote for Overdose
- Supportive care and monitoring
Storage Conditions
- Store at room temperature away from light and moisture
Pharmacokinetics
- Absorption: Well-absorbed after oral administration
- Distribution: Distributed widely throughout the body and crosses the blood-brain barrier
- Metabolism: Hepatic metabolism mainly via glucuronidation
- Excretion: Excreted primarily in the urine as metabolites
Precautions
- Use with caution in patients with a history of seizures or benzodiazepine dependence
Warnings
- Risk of precipitating benzodiazepine withdrawal in patients with physical dependence on benzodiazepines
Others
- Flumazenil has a short half-life and may need repeat dosing in cases of severe overdose